EXTERNAL QUALITY ASSURANCE PROGRAM OVERSIGHT LABORATORY

外部质量保证计划监督实验室

• 批准号: 8930890
• 负责人: MARIANNE WARD
• 金额: $ 533.6万
• 依托单位: DUKE UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2014
• 资助国家: 美国
• 起止时间: 2014-09-30 至 2015-09-29
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8930890
• 关键词: AIDS Vaccines; Antibodies; B-Lymphocytes; Biological Assay; Contracts; Databases; Development; Ensure; Enzymes; Flow Cytometry; Freezing; HIV; HIV vaccine; Immunity; Immunosorbents; Internet; Laboratories; Link; Maintenance; Peripheral Blood Mononuclear Cell; Preparation; Prevention; Process; Reagent; Shipping; Ships; Spottings; Staining method; Stains; T-Lymphocyte; Test Result; United States Food and Drug Administration; Update; Validation; Viral; base; cell bank; cytokine; evaluation/testing; novel; programs; quality assurance; repository; vector vaccine

The objective of an External Quality Assurance Program Oversight Laboratory (EQAPOL) is to maintain and update activities carried out under the Laboratory Support for AIDS Vaccine and Other Prevention Trials contract to expand functions to include support for development of the following: (1) Peripheral blood mononuclear cell (PBMC) EQA program; (2) ELISpot EQA Program; (3) Flow Cytometry EQA Program; and (4) Establish and Characterize Unique Clade Specific HIV Virus Panels all in support of identifying a candidate HIV vaccine.

外部质量保证计划监督实验室（EQAPOL）的目标是维护和更新根据艾滋病疫苗和其他预防试验实验室支持合同开展的活动，以扩展功能，包括支持以下项目的开发：（1）外周血单核细胞（PBMC）EQA计划;（2）ELISpot EQA计划;（3）流式细胞术EQA计划;（4）流式细胞术EQA计划;（5）流式细胞术EQA计划。和（4）建立和表征独特的进化枝特异性HIV病毒组，所有这些都支持鉴定候选HIV疫苗。